Ian Brown

Instrumentation Laboratory Co. manufactures diagnostic products. It offers critical care systems, hemostatis products and information management services. The firm provides services to the hospitals and clinical laboratories. Instrumentation Laboratory was founded in 1959 and is headquartered in Bedford, MA.

Life Corp. Ltd. provides funeral services. It services include funeral event advisory, venue management, certified professional embalming care, caskets sales, facilitation of cremation and burials, conducting of funerals rites and ceremony cervices, and other ancillary services. The company was founded on February 19, 2004 and is headquartered in Singapore.

RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB.

Avanti Capital is the private equity operating division of independent investment firm Avanti Capital Plc (LSE: AVA), headquartered in London.

SDP is a strategic sourcing service provider, specializing in industrial components & equipment as well as raw materials for the heavy industry, including steel, cement and food. With integrated procurement, financing and logistics solutions, customized to customers' needs, the firm provides good value results and assure timely and effective delivery. The firm currently operates own office and warehouse facilities.

Western Australian Angel Investors, Inc. is engaged in providing investment services. It create awareness of angel investing as an alternative asset class, educates investors on practice for investing in local early-stage ventures, generates efficient and deal-flow for early-stage Investors, and complement diverse and innovation ecosystem. The company was founded by Jamie Davison and Paul Kristensen in 2010 and is headquartered in Melville, Australia.

Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA.